Palo Alto, CA, United States of America

Adrienne Sallets


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):

Title: Adrienne Sallets: Innovator in Nucleic Acid Delivery

Introduction

Adrienne Sallets is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of nucleic acid delivery, holding two patents that showcase her innovative work. Her research focuses on developing advanced methods for delivering therapeutic agents into cells.

Latest Patents

Adrienne's latest patents include "Hybrid immolative cell-penetrating complexes for nucleic acid delivery." This patent provides complexes, compositions, and methods for delivering nucleic acids into cells in vivo. The innovations facilitate the complexation, protection, delivery, and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs both in vitro and in vivo. Another notable patent is "Immolative cell-penetrating complexes for nucleic acid delivery to the lung." This invention involves cationic amphipathic polymers and methods for delivering therapeutic, diagnostic, and imaging agents, including nucleic acids, into cells. These complexes enhance the targeted release of agents to specific cell types and tissues.

Career Highlights

Adrienne Sallets is affiliated with Leland Stanford Junior University, where she continues her research and development in the field of nucleic acid delivery. Her work has garnered attention for its potential applications in therapeutic and diagnostic settings.

Collaborations

Some of her notable coworkers include Tim R Blake and Robert M Waymouth, who have collaborated with her on various projects related to her patents.

Conclusion

Adrienne Sallets is a trailblazer in the field of nucleic acid delivery, with her innovative patents paving the way for advancements in therapeutic applications. Her contributions are significant in enhancing the effectiveness of drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…